INNOCOS SummitSan Francisco 2027
- TBC
- September 28-30, 2027
INNOCOS returns to Silicon Valley at the sharp end of a reset. Capital is selective, customer acquisition is breaking down, AI is rewriting how products are discovered, and consumers can finally tell the difference between performance and a good story. Three days built for the founders, executives, retailers, and investors deciding what beauty, wellness, and consumer brands will look like next.
The brands winning in 2027 are not the loudest. They are the ones who can prove what they claim, deploy capital with discipline, and show up where the next consumer actually decides, which is increasingly inside AI search, on Amazon, and on the recommendation of an expert. This is the agenda for that brand: built around the real pain points operators are wrestling with, not the buzzwords.
Forward-looking by design, the program pairs the industry’s most successful founders and retailers with the investors writing the cheques and the scientists raising the bar on proof. Every session answers a question a brand leader is already asking: where is growth real, what is fundable now, how do I scale without burning credibility, and how do I build something that lasts.
Discovery is being rewritten - The next consumer may find a product through AI search, an expert, a community, Amazon or a retailer, often moving between all of them before making a decision.
As traditional customer acquisition becomes more expensive and less predictable, brands need to understand where influence is shifting and how to become visible in a world where AI is increasingly deciding which products get recommended.
Capital has become more selective - Investors are still investing, but the bar has changed. Growth alone is no longer enough.
Strong unit economics, defensible science, a clear channel strategy and evidence of real consumer demand are becoming central to what gets funded. At the same time, capital is moving toward new opportunities across longevity, women’s health, beauty from within and GLP-1 support, while other categories are becoming increasingly crowded.
Proof is becoming a prerequisite - Consumers, retailers, regulators and investors are becoming less tolerant of science-washing and claims that go beyond the evidence.
The brands that lead the next decade will need to show not only what makes them different, but what they can actually prove. Clinical evidence, validated claims and transparent communication are becoming part of brand value.
Founders & Brand Leaders
- Founders & CEOs
- Chief Innovation / R&D Officers
- Brand & strategy leaders
- Product & formulation teams
CMOs & Marketing
- CMOs & marketing directors
- Brand equity & communications leaders
- Media, content & growth strategists
- Consumer & insight teams
Investors & Advisors
- Beauty, wellness & longevity investors
- Family offices & private equity
- Strategic advisors & board members
- M&A and corporate development
Clinicians & Retailers
- Longevity & aesthetic clinic directors
- Physicians & scientists
- Luxury & prestige retail executives
- Diagnostics & technology providers
Irina Barbalova
Global Lead, Beauty & Personal Care, Euromonitor International
Anthony Saniger
Founder & CEO, Act Second
Three days for founders, executives, investors, and clinicians building the next chapter of longevity-driven beauty and wellness. Seats are limited to keep the audience senior and the conversations real.
Questions about registration? Or would you like to pay by invoice instead? Email registration@innocosevents.com